Tan, X.
Baugh, K.
Bulman, Z. P.
Wenzler, E.
Article History
First Online: 16 May 2020
Compliance with Ethics Guidelines
:
: Eric Wenzler reports personal fees from Astellas Pharma, personal fees from Melinta Therapeutics, personal fees from Shionogi Inc., and personal fees from GenMark Diagnostics outside the submitted work. Xing Tan, Kim Baugh, and Zack Bulman declare no conflicts of interest relevant to this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.